Pages that link to "Q40550091"

The following pages link to interferon regulatory factor-1 mediates the proapoptotic but not cell cycle arrest effects of the steroidal antiestrogen ICI 182,780 (faslodex, fulvestrant). (Q40550091):

Displaying 37 items.

• Role of plasmacytoid dendritic cells for aberrant class II expression in exocrine glands from estrogen-deficient mice of healthy background (Q24273412) (← links)
• IRF-1 transcriptionally upregulates PUMA, which mediates the mitochondrial apoptotic pathway in IRF-1-induced apoptosis in cancer cells (Q24310103) (← links)
• Application of metabolomics in drug resistant breast cancer research (Q26866291) (← links)
• Antiestrogens, aromatase inhibitors, and apoptosis in breast cancer (Q28268250) (← links)
• BCL2 and CASP8 regulation by NF-kappaB differentially affect mitochondrial function and cell fate in antiestrogen-sensitive and -resistant breast cancer cells. (Q30432099) (← links)
• Pathways to tamoxifen resistance (Q30441001) (← links)
• The Wilms' tumor suppressor WT1 induces estrogen-independent growth and anti-estrogen insensitivity in ER-positive breast cancer MCF7 cells (Q33723383) (← links)
• ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer (Q33836140) (← links)
• IFNgamma restores breast cancer sensitivity to fulvestrant by regulating STAT1, IFN regulatory factor 1, NF-kappaB, BCL2 family members, and signaling to caspase-dependent apoptosis (Q34078171) (← links)
• Frequent loss of heterozygosity at the interferon regulatory factor-1 gene locus in breast cancer (Q34139499) (← links)
• Dynamic modelling of oestrogen signalling and cell fate in breast cancer cells (Q34192940) (← links)
• Combination erlotinib-cisplatin and Atg3-mediated autophagy in erlotinib resistant lung cancer (Q34465240) (← links)
• Expression of the retinoblastoma protein RbAp48 in exocrine glands leads to Sjögren's syndrome-like autoimmune exocrinopathy (Q34600485) (← links)
• Interferon regulatory factor-1 signaling regulates the switch between autophagy and apoptosis to determine breast cancer cell fate (Q35178371) (← links)
• Identification of a natural compound by cell-based screening that enhances interferon regulatory factor-1 activity and causes tumor suppression (Q35317965) (← links)
• ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer (Q35620279) (← links)
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer. (Q35684410) (← links)
• Autophagy: friend or foe in breast cancer development, progression, and treatment (Q35684456) (← links)
• RelA-Induced Interferon Response Negatively Regulates Proliferation (Q35804406) (← links)
• Endoplasmic reticulum stress, the unfolded protein response, autophagy, and the integrated regulation of breast cancer cell fate. (Q35855031) (← links)
• Tyrosine-phosphorylated caveolin-1 (Tyr-14) increases sensitivity to paclitaxel by inhibiting BCL2 and BCLxL proteins via c-Jun N-terminal kinase (JNK). (Q36006854) (← links)
• ERRβ splice variants differentially regulate cell cycle progression. (Q36187539) (← links)
• Antiestrogen Resistance and the Application of Systems Biology (Q36713946) (← links)
• ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer (Q37240697) (← links)
• Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells (Q37401741) (← links)
• IRF-1 inhibits NF-κB activity, suppresses TRAF2 and cIAP1 and induces breast cancer cell specific growth inhibition (Q38870837) (← links)
• Whole transcriptome analysis of the ERα synthetic fragment P295-T311 (ERα17p) identifies specific ERα-isoform (ERα, ERα36)-dependent and -independent actions in breast cancer cells (Q39183133) (← links)
• Biological reprogramming in acquired resistance to endocrine therapy of breast cancer. (Q39667297) (← links)
• Genome-wide Identification of IRF1 Binding Sites Reveals Extensive Occupancy at Cell Death Associated Genes (Q39683560) (← links)
• Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis (Q42477900) (← links)
• BRCA1-mimetic compound NSC35446.HCl inhibits IKKB expression by reducing estrogen receptor-α occupancy in the IKKB promoter and inhibits NF-κB activity in antiestrogen-resistant human breast cancer cells. (Q42777355) (← links)
• Interferon regulatory factor-1 regulates reconstituted extracellular matrix (rECM)-mediated apoptosis in human mammary epithelial cells (Q79176713) (← links)
• Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB (Q79874646) (← links)
• Interferon regulatory factor-1-induced apoptosis mediated by a ligand-independent fas-associated death domain pathway in breast cancer cells (Q80202673) (← links)
• Lupus-associated endogenous retroviral LTR polymorphism and epigenetic imprinting promote HRES-1/RAB4 expression and mTOR activation (Q91721378) (← links)
• A dual role of Irf1 in maintaining epithelial identity but also enabling EMT and metastasis formation of breast cancer cells (Q94671670) (← links)
• RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer (Q95801843) (← links)